Insightful article about Prinses Máxima Centrum voor kinderoncologie researchers using BioSkryb’s PTA technology and machine learning to map the DNA of cells with hereditary diseases like Fanconi anemia. BioSkryb Genomics' ResolveDNA® and ResolveOME™ are changing the way that single cell technologies are used, creating new opportunities for discovery and translational research. These amplification technologies provide scientists with the capability to generate, analyze, and interpret much more pertinent data about complex diseases, revealing new groundbreaking discoveries. Read on to learn more about the work they’re doing: https://lnkd.in/ebFWbsSJ
BIOKÉ’s Post
More Relevant Posts
-
This Mission Continues at IndyGeneUS AI!!! This is a major step towards future research studies that will address misdiagnosis of endometriosis, uterine fibroids and PCOS in underrepresented women populations globally. Understanding these conditions at the molecular level will be critical. Extremely honored that IndyGeneUS AI got to work with all the co-authors of this published paper. #genomics #diversitymatters #womenshealth #indygeneus
We are very proud to announce our first paper has been accepted for publication using Digital Twins and Genomics: “The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype Driven Variant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.” Authors and affiliations: William G. Kearns (Co-founder/CEO and Chief Scientific Officer of Genzeva and LumaGene); J. Georgios Stamoulis (QIAGEN Digital Insights); Joseph Glick and Lawrence Baisch (RYLTI BioPharma); Andrew Benner, Dalton Brough, Luke Du (Genzeva); Bradford Wilson (IndyGeneUS AI); Laura Kearns (Genzeva and LumaGene); Nicholas Ng, Maya Seshan, and Raymond Anchan (Brigham and Women’s Hospital, Harvard University). Running Title – Digital Twins and Molecular Medicine.
To view or add a comment, sign in
-
💡 Shaping Genomic Research: Oxford Global's recent conversation with the collaboration of 10x Genomics and Charité - Universitätsmedizin Berlin unveils a profound vision. Angela Churchill, Ph.D. and Philip Bischoff share their insights on the revolutionary impact of 10x's single-cell platforms and how it can reshape the future of genomics. What potential breakthroughs in medicine and science do you imagine this technology will bring? Join the conversation to share your thoughts on the transformative possibilities. Read the full interview here: https://hubs.la/Q027HKVm0 #OGOmics
To view or add a comment, sign in
-
📢 Conscience has released the results of CACHE Challenge #1, which aimed to predict "hits" for Parkinson's disease drugs through computational models. Conducted in partnership with The Structural Genomics Consortium (SGC) and funded by The Michael J. Fox Foundation for Parkinson's Research, the challenge has yielded seven promising discoveries for familial Parkinson's disease. The CACHE Challenge has two key outcomes: firstly, new discoveries that can help advance novel treatments for Parkinson’s disease, and secondly, prospective benchmarking of multiple computational methods to reveal the state-of-the-art and guide future progress. Conscience has now made the entire experimental dataset of the CACHE Challenge available to the public, including the chemical structures of all the molecules tested and associated computational methods. #Conscience #CACHEChallenge #ParkinsonsDisease #DrugDiscovery #ComputationalModels #OpenScience
To view or add a comment, sign in
-
The landmark Human Genome Project took 10 years of unprecedented collaboration and $3 billion in investment to complete. It has since contributed significantly to advances in medicine and genomics, improving our ability to understand our world and shape our future. Today, a single genomic lab can achieve the same feat (sequencing an entire human genome) in less than a day and for under CAD $1,000. This presents remarkable opportunities for innovation. But is Canada making the most of our advantages in this area? Learn more in a new op-ed about genomics research by Suzanne Gill, President and CEO of Genome British Columbia: https://lnkd.in/gC5UC2Nu
Can Canada Seize Its Opportunities in Genomics?
To view or add a comment, sign in
-
#Research | 𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗿𝗰𝗵𝗶𝘃𝗶𝗻𝗴 𝗼𝗳 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗗𝗮𝘁𝗮 | Led by Dr. Deborah M Leigh from Eidg. Forschungsanstalt WSL, an international team of researchers has achieved a significant milestone in genetic data management. They propose standardized formats for different types of genetic and genomic data, along with the mandatory inclusion of extensive metadata, enhancing data accessibility for researchers worldwide. The research emphasizes the importance of archiving genetic data in these proposed standardized formats. By ensuring comprehensive metadata and adopting these standards retroactively for older data, the research aims to enable more accessible, equitable, and innovative use of genetic data on a global scale. Photo: National Cancer Institute on Unsplash 👉 Learn more >> https://lnkd.in/gHVuWJtM 👉 Original publication >> https://lnkd.in/eSy6QSX8 🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> swissinnovation.org Follow us >> Science-Switzerland #Science | #Education | #Research | #Innovation
To view or add a comment, sign in
-
Exciting news in the field of genomics... The National Human Genome Research Institute (NHGRI) has committed $6.7 million to develop faster, cheaper, and more accurate sequencing technologies. These advancements have the potential to revolutionize healthcare, research, and medicine. 👏 👏 Check out the link below for more information. 👇 https://lnkd.in/eVVTEdGW In addition, Oxford Nanopore Technologies announced breakthrough performance data and new platform updates at their annual conference. Their direct RNA sequencing technology supports the emergence of RNA-based therapies, and they are driving towards democratizing sequencing technology for everyone, everywhere. 👏 👏 Learn more about their impressive updates in the link below.👇 https://lnkd.in/ei-g9Fmt These advancements underscore a thrilling era of innovation in genomics! #Genomics #DNASequencing #RNAResearch #Biotechnology #Innovation
To view or add a comment, sign in
-
We’re paving the way through our collaboration with CiberMed to enable a new Targeted Digital Cytometry method from bulk RNASeq data! If you are doing immune cell profiling but need a way to scale your sample numbers or address tissue dissociation bias, this method might be for you! #targetenrichment #digitalcellprofiling #cellprofiling #immunecellprofiling #deconvolution #rnaseq #cibermed
🔎Unveil a significant advancement in genomics research with Agilent SureSelect RNA-Seq, paired with iSort digital cytometry from CiberMed. This technology offers unparalleled accuracy in cell type profiling with 20x less sequencing than traditional methods. Developed with the expertise of CiberMed and Stanford University, it’s set to transform research by providing a robust, efficient, and precise solution for analyzing cell type compositions in solid tissue samples.💡 👨🔬Explore how this innovative approach can elevate your research capabilities. Dive into the detailed study to see the future of genomics. Agilent Technologies #Genomics #Innovation #Research #CiberMed #StanfordUniversity #RNASequencing #Biotech
To view or add a comment, sign in
-
ICYMI: Recent advancements in #spatial #omics have transformed genomics, allowing us to analyze cellular function within their native tissue environment. However, challenges like noise and limited resolution hinder current methods. Our recent blog explores a novel technique that overcomes these limitations. Read more: https://lnkd.in/dnmktd7w #SpatialTranscriptome #multiomics #singlecell
To view or add a comment, sign in
-
🌟 Your inside look of the latest foundational models in biotech and pharma 🌟 To keep up with the rapid acceleration of model development, we’ve created an interactive foundational model map for finding the foundational models for specific use cases. In the map, you can toggle between: - 7 key domains - 59 foundational models - 837 use cases Key domains we’ve covered: - Genomics and genetic analysis - Epigenetics - Single-cell and multi-omics analysis - Molecular structures and interactions - Discovery and biomedical applications - Imaging This map lets you organize foundational models by input and output types, such as molecules, sequences, and structure tables. You can utilize it to map use cases directly to the relevant models, providing a practical approach beyond mere semantic definitions of domains. Try it out yourself! 👇 https://lnkd.in/eQHwfhhV #biotech #research #dataanalytics
To view or add a comment, sign in
-
In the realm of life sciences and genetics, individuals often find themselves on unique journeys that intersect with significant advancements shaping the fields of science and medicine. Zhang Guocheng embarked on a career that took himself into the world of science and genomics and eventually led him to the #BGI Group, as a Deputy General Manager of BGI Genomics at present. By exploring his story, we discover a narrative of dedication, innovation, and a deep commitment to the belief that genomics technology can have a significant impact on improving people’s lives. Read: https://bit.ly/3RBzbUh
A Path to Advancing Science and Medicine for Human Health: A Conversation with Zhang Guocheng of BGI Genomics
en.genomics.cn
To view or add a comment, sign in
2,054 followers